KOR  ENG
  • NEWS

  • AbClon’s strong foundations and innovative platforms will help drive the future of
    personalized medicine and safeguard the health and hopes of families.

뉴스

제목 Investigator-initiated trial (IIT) of AT101 for relapsed/refractory patients on CAR-T
첨부파일 - 날짜 2024-04-30 조회 63

N/A

Designed by CHAIRONE
© AbClon. All rights reserved.